SpectronRx
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Indiana, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
17490 Dugdale Dr, South Bend, Indiana, 4...Phone Number
(574) 271-2800Website
www.spectronrx.comRevenue
$58.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About SpectronRx
SpectronRx is a U.S.based radiopharmaceutical contract development and manufacturing organization (CDMO/CMO) that supports the development, labeling, production, and global supply of therapeutic and diagnostic isotopes and radiopharmaceutical products. Its facilities are designed for good manufacturing practice (GMP) compliance and support advanced radioligand therapies and diagnostic drugs used in precision medicine and nuclear medicine applications. SpectronRx emphasizes scientific rigor, quality systems, and integrated services to help partners navigate complex regulatory pathways and scale manufacturing.Explore more
SpectronRx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SpectronRx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
SpectronRx, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when SpectronRx launches new products
Congratulate Masked Content for being promoted to Masked Content at SpectronRx
Click to see if SpectronRx had a recent Job posting/layoffs
Earning: See what the market has to say on SpectronRx recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if SpectronRx is spiking on competitors!
Check if SpectronRx has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once SpectronRx has new funding data
Recommended Actions
Find VP level buyers at SpectronRx
Find more new buyers
Compare Similar Companies to SpectronRx
Compare insights from companies similar to SpectronRx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$169.8M
501-1,000
Private
-
1999
VJ
Valentino JoanneVice President of Minaris Regenerative Medicine, LLC
Company Profile Activity
Activity Insights
SpectronRx is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
SpectronRx is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about SpectronRx.
SpectronRx financials insights
Gather financial insights about SpectronRx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Unspecified
$85M
SpectronRx Tech Stack
A closer look at the technologies used by SpectronRx
See more technologies
SpectronRx News & Media
SpectronRx Secures $85 Million to Expand Medical Isotope Production, CDMO and CMO ...
34-acre campus supports 200,000 square feet of GMP manufacturing, with long-term expansion capacity exceeding one million square feetClarity enters a Commercial Manufacturing Agreement for Cu-64 SAR-bisPSMA with SpectronRx
Highlights Clarity has entered into a Commercial Manufacturing Agreement with SpectronRx for 64Cu-SAR-bisPSMA. SpectronRx's facility in Indiana will provide on-demand commercial-scale manufacturing of both copper-64 and 64Cu-SAR-bisPSMA under one roof and enables distribution to all 50...Cellectar Biosciences and SpectronRx Partner to Manufacture Novel Phospholipid Radioconjugate for the Treatment of Cancer
Cellectar broadens global manufacturing network in preparation for potential commercialization of Iopofosine I 131 in 2025 Cellectar broadens global manufacturing network in preparation for potential commercialization of Iopofosine I 131 in 2025Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership
Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SpectronRx
Sign Up For FreeTo access detailed company insights
SpectronRx is a U.S.based radiopharmaceutical contract development and manufacturing organization (CDMO/CMO) that supports the development, labeling, production, and global supply of therapeutic and diagnostic isotopes and radiopharmaceutical products. Its facilities are designed for good manufacturing practice (GMP) compliance and support advanced... Read More
